Pyxis Oncology, Inc. (PYXS) Social Stream
Pyxis Oncology Inc (PYXS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Pyxis Oncology Inc.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-19 | 4 | $25 | $16 | $22 | $3.59 | 512.81% |
2022-03-29 | 4 | $25 | $15 | $20 | $3.59 | 457.1% |
PYXS reports an average of 202.05% for its upside potential over the past 147 days.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-02 | 4 | 25 | 16 | 22.000 | 13.30 | 65.41% |
2021-11-15 | 4 | 25 | 16 | 22.000 | 12.06 | 82.42% |
2021-11-19 | 4 | 25 | 16 | 22.000 | 12.92 | 70.28% |
2022-03-22 | 4 | 25 | 15 | 21.666 | 4.92 | 340.37% |
2022-03-29 | 4 | 25 | 15 | 20.000 | 4.88 | 309.84% |
PYXS Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1.5 | 3 | 0 | 1 | 0 | 0 | 4 |
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, Pyxis Oncology Inc's upside potential (average analyst target price relative to current price) is higher than 289.3% of them.
- To contextualize these metrics, consider that out of all US stocks, Pyxis Oncology Inc's number of analysts covering the stock is higher than 57.24% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, Pyxis Oncology Inc's average analyst price target is greater than 104.88% of them.
- PYXS has a lower variance in analysts' estimates than -87.18% of stocks in the small market cap category.
Stocks similar to Pyxis Oncology Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PVCT, PRVB, and PRTK.
Is PYXS a Buy, Hold or Sell? See the POWR Ratings now!